These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 12724015

  • 21. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [Abstract] [Full Text] [Related]

  • 22. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.
    Łukaszkiewicz J, Karczmarewicz E, Płudowski P, Jaworski M, Czerwiński E, Lewiński A, Marcinowska-Suchowierska E, Milewicz A, Spaczyński M, Lorenc RS, EPOLOS Group.
    Med Sci Monit; 2008 Dec; 14(12):PH65-70. PubMed ID: 19043376
    [Abstract] [Full Text] [Related]

  • 23. [The evaluation of bone mineral density and selected markers of bone turnover in patients with insulin dependent diabetes mellitus].
    Miazgowski T, Andrysiak-Mamos E, Pynka S, Gulińska M, Czekalski S.
    Przegl Lek; 1997 Dec; 54(7-8):533-9. PubMed ID: 9480464
    [Abstract] [Full Text] [Related]

  • 24. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A, Kalai E, Hadj Salah M, Bouzid K, Zerelli L.
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [Abstract] [Full Text] [Related]

  • 25. Attainment of peak bone mass and bone turnover rate in relation to estrous cycle, pregnancy and lactation in colony-bred Sprague-Dawley rats: suitability for studies on pathophysiology of bone and therapeutic measures for its management.
    Sengupta S, Arshad M, Sharma S, Dubey M, Singh MM.
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):421-9. PubMed ID: 15876407
    [Abstract] [Full Text] [Related]

  • 26. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, Shenkier TN, Tozer RG, Palmer MJ, Shepherd LE, Liu S, Tu D, Goss PE.
    J Clin Oncol; 2006 Aug 01; 24(22):3629-35. PubMed ID: 16822845
    [Abstract] [Full Text] [Related]

  • 27. Diabetes in postmenopause: different influence on bone mass according to age and disease duration.
    Hadjidakis DI, Androulakis II, Mylonakis AM, Sfakianakis ME, Raptis AE, Papaefstathiou AG, Economopoulos TC, Raptis SA.
    Exp Clin Endocrinol Diabetes; 2009 May 01; 117(5):199-204. PubMed ID: 19085699
    [Abstract] [Full Text] [Related]

  • 28. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP, Liao EY, Wu XP, Cao XZ, Shan PF, Su X.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):371-5. PubMed ID: 16677543
    [Abstract] [Full Text] [Related]

  • 29. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
    Shaarawy M, Zaki S, Sheiba M, El-Minawi AM.
    Clin Lab; 2003 Feb 14; 49(11-12):625-36. PubMed ID: 14651333
    [Abstract] [Full Text] [Related]

  • 30. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T.
    Menopause; 2008 Feb 14; 15(2):369-73. PubMed ID: 17882010
    [Abstract] [Full Text] [Related]

  • 31. Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus.
    Lumachi F, Camozzi V, Tombolan V, Luisetto G.
    Ann N Y Acad Sci; 2009 Sep 14; 1173 Suppl 1():E64-7. PubMed ID: 19751417
    [Abstract] [Full Text] [Related]

  • 32. Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus.
    Sahin G, Polat G, Bagis S, Milcan A, Erdogan C.
    J Womens Health (Larchmt); 2002 Nov 14; 11(9):801-4. PubMed ID: 12626079
    [Abstract] [Full Text] [Related]

  • 33. Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus.
    Safaei H, Janghorbani M, Aminorroaya A, Amini M.
    Acta Diabetol; 2007 Jun 14; 44(2):76-82. PubMed ID: 17530471
    [Abstract] [Full Text] [Related]

  • 34. Uncoupling of bone turnover following hip replacement.
    Whitson H, DeMarco D, Reilly D, Murphy S, Yett HS, Mattingly D, Greenspan SL.
    Calcif Tissue Int; 2002 Jul 14; 71(1):14-9. PubMed ID: 12200656
    [Abstract] [Full Text] [Related]

  • 35. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
    Celi M, Balducci S, Schiappoli A, Caliumi C, Petramala L, Cerci S, Cotesta D, D'Erasmo E, Letizia C.
    Ann Ital Med Int; 2003 Jul 14; 18(2):89-98. PubMed ID: 12886826
    [Abstract] [Full Text] [Related]

  • 36. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O, Magnusson P, Toss G, Larsson L.
    Clin Chim Acta; 2005 Jun 14; 356(1-2):67-75. PubMed ID: 15936304
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Christensen JO, Svendsen OL.
    Osteoporos Int; 1999 Jun 14; 10(4):307-11. PubMed ID: 10692980
    [Abstract] [Full Text] [Related]

  • 39. Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed Type 2 diabetes: a 12-month follow-up.
    Miazgowski T, Noworyta-Ziętara M, Safranow K, Ziemak J, Widecka K.
    Diabet Med; 2012 Jan 14; 29(1):62-9. PubMed ID: 21726281
    [Abstract] [Full Text] [Related]

  • 40. Bone marker alterations in patients with type 1 Gaucher disease.
    Ciana G, Martini C, Leopaldi A, Tamaro G, Katouzian F, Ronfani L, Bembi B.
    Calcif Tissue Int; 2003 Mar 14; 72(3):185-9. PubMed ID: 12522660
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.